RxDoctor Payments Data

Leslie Kingsley, DO

Family Medicine · Muskegon, MINPI 1043579014

Payments from drug & device makers

$530in general payments, 2019–2025

Across 27 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$146
  • Novo Nordisk$88
  • Welch Allyn$57
  • Lilly USA, LLC$54
  • Otsuka America Pharmaceutical, Inc.$41
  • Amgen$40
  • plus $104 from 5 others

What the payments were for

  • Food & beverage$45886%
  • Education$153%
  • Other$5711%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$530 in reported general payments places this provider in the 60th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$3,185
Medicare patients
82
Services billed
177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate24$187,554
TrulicityDulaglutide86$89,829
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$22,154
EliquisApixaban24$21,140
InvokanaCanagliflozin12$13,398
OzempicSemaglutide12$10,908
FarxigaDapagliflozin Propanediol19$10,003
Spiriva HandihalerTiotropium Bromide13$9,667
SymbicortBudesonide/Formoterol Fumarate29$6,987
Praluent PenAlirocumab12$5,674
TrintellixVortioxetine Hydrobromide12$5,123
Lantus SolostarInsulin Glargine,hum.Rec.Anlog36$4,201
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen221$3,528
Albuterol Sulfate HfaAlbuterol Sulfate82$2,584
Ventolin HfaAlbuterol Sulfate35$2,206

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$38$187,55424 claims
Lilly USA, LLCTrulicity$54$89,82986 claims
PfizerEliquis$12$21,14024 claims
Novo NordiskOzempic$88$10,90812 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$15$5,12312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Muskegon

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →